Genmab A/S Announces Orbis Investment Management Limited Crosses 5% Ownership Threshold

On April 1, 2026, Genmab A/S filed a Form 6-K reporting a major shareholder notification. Orbis Investment Management Limited, an entity controlled by the Allan & Gill Gray Foundation, disclosed that as of March 31, 2026, it crossed the 5% ownership threshold in Genmab. Specifically, Orbis now controls 3,221,620 shares, representing 5.0141% of Genmab\'s total share capital and voting rights. This is an increase from its previous reported position of 4.9895%. The notification was made in accordance with Section 30 of the Danish Capital Markets Act. The filing includes a detailed chain of controlled undertakings, identifying the Allan & Gill Gray Foundation as the ultimate controlling entity through Orbis Allan Gray Limited, Orbis Holdings Limited, and Orbis Investment Management Limited. No other material corporate developments, clinical trial updates, or financial results were disclosed in this specific filing.